Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses? [electronic resource]
Producer: 20130128Description: 606-11 p. digitalISSN:- 1537-453X
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.